Articles with "malignant meningiomas" as a keyword



Photo from wikipedia

Seizures in surgically resected atypical and malignant meningiomas: Long-term outcome analysis

Sign Up to like & get
recommendations!
Published in 2018 at "Epilepsy Research"

DOI: 10.1016/j.eplepsyres.2017.12.013

Abstract: PURPOSE Seizures in rare atypical and malignant meningiomas were significantly under-studied. Our aim was to examine the rates, predictors, and seizure control in these meningiomas, and to analyze associations between clinical characteristics and seizure free… read more here.

Keywords: meningiomas; atypical malignant; seizures surgically; preoperative seizures ... See more keywords
Photo from wikipedia

Targeting the CSF1/CSF1R Axis is a Potential Treatment Strategy for Malignant Meningiomas.

Sign Up to like & get
recommendations!
Published in 2021 at "Neuro-oncology"

DOI: 10.1093/neuonc/noab075

Abstract: BACKGROUND Malignant meningiomas are fatal and lack effective therapy. As M2 macrophages are the most prevalent immune cell type in human meningiomas, we hypothesized that normalizing this immunosuppressive population would be an effective treatment strategy.… read more here.

Keywords: treatment; meningiomas; malignant meningiomas; csf1 csf1r ... See more keywords
Photo from wikipedia

Epidemiology and survival of non-malignant and malignant meningiomas in middle-aged females, 2004-2018

Sign Up to like & get
recommendations!
Published in 2023 at "Frontiers in Oncology"

DOI: 10.3389/fonc.2023.1157182

Abstract: Background The incidence of meningioma is disparate to sex: meningiomas are more common in women than in men, especially in middle-aged women. Understanding the epidemiology and survival of middle-aged women with meningiomas would help estimate… read more here.

Keywords: non malignant; middle aged; malignant meningiomas; epidemiology ... See more keywords

Inhibiting PP2A Upregulates B7-H3 Expression and Potentially Increases the Sensitivity of Malignant Meningiomas to Immunotherapy by Proteomics

Sign Up to like & get
recommendations!
Published in 2022 at "Pathology and Oncology Research"

DOI: 10.3389/pore.2022.1610572

Abstract: Malignant meningiomas have a high mortality rate and short survival time and currently have no effective treatment. In our study, proteomics analysis was performed to identify highly expressed proteins as therapeutic targets in malignant meningiomas.… read more here.

Keywords: immunotherapy; pp2a; meningiomas; sensitivity malignant ... See more keywords